Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

NeuroSearch initiates phase I clinical study of NSD-644 for the treatment of pain

Dec. 7, 2007

Eisai and BioArctic sign licensing agreement for BAN-2401 for Alzheimer's disease

Dec. 7, 2007

Rasagiline may slow deterioration of amyotrophic lateral sclerosis

Dec. 7, 2007

Novel therapeutic agents for neurological disorders reported in recent patents

Dec. 7, 2007

Targacept reports negative results from phase II clinical trial of TC-2696

Dec. 7, 2007

Alpharma reports positive results from phase III trial of ALO-01 for pain relief

Dec. 7, 2007

Preclinical data on AV-101 indicate its potential for the treatment of PD

Dec. 7, 2007

EMEA accepts for filing UCB's MAA for Neupro for restless legs syndrome

Dec. 5, 2007

AVI-4658 granted fast track status for Duchenne muscular dystrophy

Dec. 5, 2007

GW Pharmaceuticals initiates phase III clinical trial of Sativex for MS spasticity

Dec. 5, 2007

Popular Stories

Today's news in brief
BioWorld
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...